Because cabozantinib induces apoptosis in colon cancer cells independent of p53 activity [36], the apoptosis-inducing activity of cabozantinib and compound 4 in Hep3B and A549 cells was also evaluated by fluorescence-activated cell sorting (FACS). Here, TP53 is linked to colonic neoplasm.